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Hyperthermia Induces Endoplasmic
Reticulum-Mediated Apoptosis in Melanoma and
Non-Melanoma Skin Cancer Cells
Yiqun G. Shellman1, William R. Howe1, Leslie A. Miller1, Nathaniel B. Goldstein1, Theresa R. Pacheco1,
Roop L. Mahajan2, Susan M. LaRue3 and David A. Norris1,4
Hyperthermia has been revived as a promising approach for cancer treatment. To understand the underlying
mechanisms of hyperthermic killing of cancer cells, we examined the cytotoxic effects of hyperthermia on
various skin cancer cell lines using cell viability, morphological analyses, and caspase activation assays.
Hyperthermia induced cytotoxicity in a time- and temperature-dependent manner. At middle dose/time
combinations, heat-induced apoptosis, whereas at higher doses, necrosis was the mechanism of cell death. To
investigate the mechanisms of hyperthermia-induced apoptosis, we examined the activation of extrinsic
(Caspase 8) and intrinsic (Caspase 9) apoptotic pathways. Hyperthermia did not activate Caspases 8 or 9, but did
activate Caspase 3/7, suggesting a non-conventional apoptotic pathway. Last, analysis of Grp78 expression and
Caspase 12 or 4 activation indicated that hyperthermia induced endoplasmic reticulum-mediated apoptosis.
Thus, hyperthermia induced apoptosis in two types of skin cancer cells through endoplasmic reticulum-
mediated apoptosis and not through the classical intrinsic or extrinsic apoptosis pathways. Hyperthermia may
be a promising treatment for basal cell carcinoma and melanoma, bypassing the antiapoptotic defenses
concentrated in the intrinsic and extrinsic apoptosis pathways. These results also raise the possibility that heat
may be combined with other approaches for induction of apoptosis to achieve synergistic killing of skin
cancers.
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INTRODUCTION
There is a renewed interest in hyperthermia as a cancer
treatment since new technology provides precise control and
measurement of heat delivery (Jones et al., 2005; Coffey
et al., 2006). Promising results from recent clinical trials
indicate the effectiveness of hyperthermia treatment as an
adjunct to radiotherapy or chemotherapy in treating numer-
ous cancers, including superficial cutaneous tumors, recur-
rent breast cancer, recurrent malignant melanoma, head and
neck squamous cell carcinoma, lymph node metastases,
glioblastoma, and cervical carcinoma (Jones et al., 2005;
Coffey et al., 2006).
Hildebrandt et al. (2002) provided a thorough summary of
the current understanding of hyperthermia effects at cellular
and molecular levels, and highlighted the limitation of
hyperthermia studies performed in the 1970s and early
1980s when techniques were insufficient. They also pointed
out that further basic research is needed to fully utilize and
optimize hyperthermia treatments. A detailed understanding
of the mechanisms through which hyperthermia kills tumor
cells would provide useful information and allow engineers
to develop more efficacious applicators while minimizing
adverse events and bystander tissue damage.
The mechanisms through which hyperthermia induces
apoptosis in skin tumor cells is one of the major aims of this
study. Apoptosis has been recognized as the major pro-
grammed cell death mechanism since the seminal article of
Kerr et al. (1972). Conventionally, it is believed that induction
of apoptosis involves the activation of a complex array of
caspases through two major apoptotic pathways: extrinsic or
intrinsic apoptotic pathways.
The extrinsic pathway involves death receptor binding to
proapoptotic death ligands such as tumor necrosis factor-a,
Fas, and tumor necrosis factor related apoptosis including
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apoptosis including ligand
ligand (TRAIL) and activation of Caspase 8. Subsequent direct
activation of effector caspases, such as Caspase 3 in a
mitochondria-independent fashion, leads to cell death
(Chinnaiyan et al., 1996; Tschopp et al., 1998).
In contrast, the intrinsic pathway involves mitochondrial-
dependent cell death induced by cytotoxic, genotoxic, or
stress-inducing agents. These agents induce mitochondria
damage and result in the release of several death-promoting
factors and activation of Caspase 9 (Li et al., 1997; Zou et al.,
1997), which then activates Caspase 3 and other effector
caspases that eventually lead to cell death.
In addition to these two major apoptotic pathways, recent
studies implicate the importance of a non-conventional
apoptotic pathway that can be induced by some apoptotic
triggers: the endoplasmic reticulum (ER)-mediated pathway
(see review Boyce and Yuan, 2006).
The ER is responsible for the synthesis, initial post-
translational modification, and proper folding of proteins, as
well as their sorting and export for delivery to appropriate
cellular destinations. Disruption in Ca2þ homeostasis, inhibi-
tion of protein glycosylation, and accumulation of misfolded
proteins may all induce ER stress, which is associated with a
range of diseases, including ischemia/reperfusion injury,
neurodegeneration, and diabetes (Kaufman, 2002; Boyce and
Yuan, 2006; Zhang and Kaufman, 2006).
The proper functioning of the ER is critical for numerous
aspects of cell physiology. Accordingly, to ensure that cells
maintain proper ER homeostasis, the ER in eukaryotic cells
has evolved highly specific signaling pathways including the
unfolded protein response (Kaufman, 2002; Boyce and Yuan,
2006; Zhang and Kaufman, 2006). Normally, unfolded
protein response is activated to protect cells that are
experiencing ER stress. However, sustained or intense ER
stress can lead to apoptosis (see review Boyce and Yuan,
2006; Zhang and Kaufman, 2006).
Grp78, also referred to as BiP, is an ER chaperone protein.
It has been indicated as the master unfolded protein response
regulator and is significantly upregulated by ER stress (see
review Boyce and Yuan, 2006; Zhang and Kaufman, 2006).
Grp78 is also a central regulator of ER function due to its roles
in protein folding and assembly, targeting misfolded proteins
for degradation, ER Ca2þ binding, and controlling the
activation of transmembrane ER stress sensors. Thus, upre-
gulation of Grp78 is a good indicator of ER stress (Li and Lee,
2006; Zhang and Kaufman, 2006).
When an overload of unfolded or misfolded proteins in the
ER is not resolved, prolonged or severe unfolded protein
response activation will lead to apoptosis (see review Boyce
and Yuan, 2006; Zhang and Kaufman, 2006). Although the
detailed mechanisms by which ER stress leads to cell death
remain enigmatic (see review Xu et al., 2005), Caspase 12 in
mice has been revealed as a major ER-associated proximal
caspase of the caspase activation cascade, and activation of
Caspase 12 eventually leads to activation of Caspase 3/7 and
apoptosis (Nakagawa et al., 2000). The loss of full-length pro-
Caspase 12 has been used in many studies to detect
activation of Caspase 12 and thus ER-mediated apoptosis.
However, human Caspase 12 contains several mutations,
which renders it non-functional (Fischer et al., 2002). It has
been reported that human Caspase 4, which is also a resident
of the ER, might be the counterpart of murine Caspase 12 and
is similarly activated by ER stress (Kim et al., 2006).
Owing to their complexity, new aspects of apoptotic
pathways are still being investigated for more than 30 years
after the seminal article about apoptosis was published (Kerr
et al., 1972). ER-mediated apoptosis is one of the newly
recognized components of apoptotic pathways (see review
Boyce and Yuan, 2006). However, to our knowledge, there
are no current studies that investigate whether hyperthermia
induces ER-mediated apoptosis in melanoma and non-
melanoma skin cancer cells.
In this study, we examined the cytotoxicity of hyperther-
mia treatments on several cutaneous cell lines and investi-
gated the apoptotic cell death pathways induced by these
hyperthermia treatments.
RESULTS
Hyperthermia induced cytotoxicity in multiple cutaneous cell
lines
We examined the cytotoxic effects of hyperthermia treat-
ments on various cutaneous cell lines by a tetrazolium
compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS)
assays. We found that hyperthermia reduced cell viability/
proliferation in a time- and temperature-dependent manner
in all the cells tested (Figure 1 and data not shown), and
Figure 1 shows the examples of a few cell lines we tested.
Cell sensitivity to hyperthermia treatment varied among
different cell lines, and the basal cell carcinoma (BCC)
cell line ASZ001 was quite sensitive (Figure 1 and data
not shown).
Hyperthermia stimulated Caspase 3/7 activity under certain
conditions
To examine whether these hyperthermia treatments induce
apoptosis, we analyzed the activation of Caspase 3/7 (the
apoptotic effector caspases) using the Caspase 3/7 Glo assay
in several different cell lines. We found that at 45 1C for
60–120minutes and at 48 1C for 15–30minutes treatments
induced caspase 3/7 activity, suggesting that apoptosis
occurred under limited time/temperature conditions
(Figure 2). We have observed similar results in multiple cell
lines including ASZ001, A375, HS294T, and WM35 cells
(Figure 2 and data not shown).
Hyperthermia induced apoptosis at mild temperature (45 1C),
but necrosis at high temperature (48 1C)
To examine the kinetics of hyperthermia-induced cytotoxi-
city, we performed MTS viability and Caspase 3/7 activity
assays at indicated post-treatment time points of both 45 and
48 1C for 90minutes. We found that hyperthermia at either 45
or 48 1C decreased cell viability starting 3 hours post-
treatment in ASZ001 cells (Figure 3). Although both
treatments decreased cell viability, only the 45 1C treatment
activated Caspases 3/7. Caspase 3/7 activation appreciated
6 hours after treatment and peaked at 12 hours post-treatment
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in the ASZ001 cells (Figure 3). We also observed similar
results in A375 cells (data not shown).
To examine further whether hyperthermia induced apop-
tosis or necrosis, we performed ethidium bromide and
acridine orange (EB/AO) morphologic assays with ASZ001
cells (Figure 4). This assay is based on the detection of
changes in nuclear morphology that are characteristically
specific for apoptosis and necrosis. Apoptosis induces
characteristic nuclear condensation and fragmentation,
whereas necrosis is characterized by the inability to exclude
vital dye, leading to orange staining nuclei. The staining
characteristics are: live cells have normal nuclei staining,
which present green chromatin with organized structures;
apoptotic cells contain condensed or fragmented chromatin
(green or orange); and necrotic cells have similar normal
nuclei staining as live cells except the chromatin is orange
instead of green.
The untreated cells in the left panel show few apoptotic
cells. The majority of the cells show large intact green nuclei.
The panels of cells exposed to either 45 or 48 1C show
progressive cell death increasing to 12 hours post-hyperther-
mia treatment. Differences between the two temperature
treatments are apparent at 12 hours, in the far right panels. In
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Figure 1. Hyperthermia induced cytotoxicity in multiple cutaneous cell
lines. Cells were seeded in 96-well plates overnight before being treated at the
indicated temperature (1C) for the indicated amount of time. MTS assays
were performed 24 hours after treatment. Viability at 37 1C of each cell line
was set as 100%. Percentages of cell viability at other temperatures were
compared to the cell viability of 37 1C. (a) Viability at 41 1C. (b) Viability
at 45 1C. (c) Viability at 48 1C. Error bars were defined as ‘‘mean7SEM,’’ and
there were 6–8 samples for each point.
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Figure 2. Hyperthermia stimulated Caspase 3/7 activity under certain
conditions. Cells were seeded in 96-well plates overnight before being treated
at the indicated temperature (1C) for the indicated amount of time (minutes).
Caspase 3/7 Glo activity assays were performed 24 hours after treatment.
Caspase 3/7 activity of 37 1C of each cell line was set as 1. Activities of
other temperatures were compared to that of 37 1C. Error bars were defined
as ‘‘mean7SEM,’’ and n¼3.
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Figure 3. Time-course experiments with hyperthermia treatment of ASZ001
cells. Cells were seeded in 96-well plates overnight before being treated
at the indicated temperature for indicated amount of time. MTS cell viability
assays and Caspase 3/7 activity Glo assays were performed according
to the manufacturer’s instructions at the indicated amount of post-treatment
time. (a) Cell viability assays. Viabilities of cells in the 37 1C incubator at
each time point were set at 100%. Error bars were defined as ‘‘mean7SEM,’’
and there were 6–8 samples for each point. (b) Caspase 3/7 activity assay.
Error bars were defined as ‘‘mean7SEM,’’ and n¼3.
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the cells exposed to 45 1C, multiple apoptotic cells are seen.
These cells are characterized by condensed and/or fragmented
nuclei, stained either green or red. In the cells exposed to 48 1C,
dead cells are largely necrotic, showing intact nuclei stained
orange indicating the inability to exclude vital dye. Thus,
Figure 4 shows that both hyperthermia treatments (45 and
48 1C) induced cell death, decreasing live cells, and increasing
cells showing characteristics of apoptosis or necrosis. However,
treatment at 45 1C induced primarily apoptotic cells, whereas
treatment of 48 1C induced predominantly necrotic cells.
Similar results were observed with A375 cells (data not shown).
Hyperthermia induced activation of Caspase 3, but not Caspase
8 or 9
To investigate whether hyperthermia activated intrinsic or
extrinsic apoptotic pathways, we examined the activation of
Caspase 8 (extrinsic) or Caspase 9 (intrinsic) in addition to
Caspase 3 using Caspase Glo assays. Lysates from Jurkat cells
treated with anti-Fas antibodies for 5 hours were used as a
positive control, and both Caspase 8 and 9 assays worked
properly (Figure 5a). In ASZ001 cells, even though a high
level of Caspase 3 activation was observed with the 45 1C
hyperthermia treatment, surprisingly neither 45 nor 48 1C
hyperthermia treatments activated Caspase 8 or 9 (Figure
5b–d). Similar results have been observed in A375 cells
(Figure 6). These data suggest that hyperthermia induced
caspase 3-dependent apoptosis, independent of the intrinsic
or extrinsic pathways.
Hyperthermia induced ER stress and ER-mediated apoptosis
ER-mediated apoptosis might be induced by hyperthermia as
neither intrinsic nor extrinsic pathways were activated by
hyperthermia in these cells. As stated earlier, induction of
Grp78 expression is a good indicator of ER stress, and
disappearance of full-length Caspase 4 or 12 signifies ER-
mediated apoptosis. Thus, to examine the effects of
hyperthermia on ER stress and ER-mediated apoptosis, we
performed western blot to measure the expressions of Grp78
and full-length Caspase 12 or 4 on hyperthermia treatment
under the apoptosis-inducing conditions (Figure 7).
Hyperthermia significantly upregulated Grp78 expression
in both A375 (Figure 7a) and ASZ001 cells indicating that ER
stress was activated at multiple time points (Figure 7b). In
addition, hyperthermia decreased full length Caspase 4 in the
human cell line A375 and full length Caspase 12 in the
mouse cell line ASZ001 (Figure 7a and b), suggesting that
activation of these caspases occurred on these hyperthermia
treatments.
DISCUSSION
Methods of treating cancer are as varied as the forms of the
disease. Treatment techniques include naturally occurring
(Bai et al., 2003; Wolf et al., 2007) or synthetic (Oltersdorf
et al., 2005) chemotherapeutic agents and radiation therapy.
In addition, hyperthermia treatment is a new promising
cancer therapy. ER-mediated apoptosis has only recently
been recognized as one of the important components of
apoptotic pathways (Boyce and Yuan, 2006). Thus, this report
attempts to determine if hyperthermia induces ER-mediated
apoptosis in melanoma and non-melanoma skin cancer cells.
We examined whether hyperthermia treatments induce
apoptosis in various skin cancer cell lines, and aimed to
clarify the mechanism through which the apoptotic pathway
is induced. We found that hyperthermia killed most cells in a
temperature- and time-dependent manner (Figure 1). Further,
these cells seem to have a wide range of sensitivity to
hyperthermia (Figure 1 and data not shown). Our results from
MTS assays are consistent with many studies that used
clonogenic assays previously (Sapareto et al., 1978; Hahn,
1984), which validate our approaches. Our study also
suggests that the BCC cell line ASZ001 was quite sensitive
to hyperthermia treatments (Figure 1), and thus hyperthermia
may be worthy of further investigation for treating BCCs. BCC
is a malignancy arising in the superficial epidermis, which
would allow for sufficient and accurate delivery of heat doses
to the tumors with little collateral tissue damage.
The Caspase 3/7 activation assays and EB/AO morpho-
logic assays collectively indicate that hyperthermia induces
apoptosis under mild conditions (Figures 2–4). In contrast to
the wide-spread destructive inflammatory features seen in
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Figure 4. Representative pictures of EB/AO staining at indicated time points. The same experimental settings were used as in Figure 3. The EB/AO
staining method was used to assess the cell status at the indicated amount of post-treatment time (hours). Arrows point to the cells representing certain cell viable
status: L, is the live cells; A, the apoptotic cells; and N, the necrotic cells. Bar¼200 mm.
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cell death induced by necrosis, apoptotic cell death does not
induce inflammation and results in targeted discrete cell
death with fewer local side effects, such as reduced scarring.
We propose that identifying the conditions that favor
apoptosis in hyperthermia-treated BCCs in the future will
maximize tumor killing and minimize bystander tissue
damage and scarring.
When we investigated the apoptotic pathways which
hyperthermia induces, surprisingly, we found that neither
Caspase 8 nor 9 were activated in these cells, even though
the same conditions did activate effector Caspase 3/7 very
efficiently (Figures 4–6). However, hyperthermia activated
Caspase 12/4 (Figure 7). These data imply that hyperthermia
treatments induce ER-mediated apoptosis but not through the
extrinsic or intrinsic pathways.
It has long been speculated that the destruction of cancer
cells at elevated temperatures is probably due to damage in the
plasma membrane, the cytoskeleton organization and the cell
nucleus, or inhibition of DNA repair enzyme (Romer, 1999;
Hildebrandt et al., 2002). However, most of these claims have
not been proved, and some of the results might also be explained
by unspecific protein inactivation (Hildebrandt et al., 2002).
The idea that hyperthermia induces ER-mediated apopto-
sis does not contradict the earlier studies mentioned above,
and it might even help explain some of the early results. The
ER encompasses about one-half of the total membrane area
and one-third of the newly translated proteins in a typical
eukaryotic cell (Boyce and Yuan, 2006). In fact, hyperthermia
has been reported to change cytoskeleton organization that
includes the ER (Hildebrandt et al., 2002) and has been
shown to disrupt Ca2þ levels in human lung cancers
(Hashimoto et al., 2003).
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Figure 5. Hyperthermia induced activation of Caspase 3, but not Caspase 8
or 9 in ASZ001 cells. Cell lysates from Jurkat treated with PBS or 100 ngml1
of anti-Fas antibody for 5 hours were used as positive controls for (a) Caspases
8 and 9 activity assays. The same experimental settings were used as in
Figure 3 for (b) Caspase 8, (c) 9, or (d) 3/7 activity. Glo assays were performed
according to the manufacturer’s instructions at the indicated post-treatment
time. Error bars were defined as ‘‘mean7SEM,’’ and n¼3.
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Figure 6. Hyperthermia induced activation of Caspase 3, but not Caspase 8
or 9 in A375 cells. The same experimental settings were used as in Figure 5,
except that A375 cells were used here instead of ASZ001. Caspase G10
activity assays were performed for (a) Caspase 8, (b) Caspase 9, and
(c) Caspase 3/7 at the indicated post-treatment time. Error bars were defined
as ‘‘mean7SEM,’’ and n¼3.
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It is well known that heat induces heat-shock proteins as a
stress response. Interestingly, heat-shock proteins are protein
chaperones in the cytoplasm and are upregulated by various
stress stimuli that damage proteins and promote accumula-
tion of misfolded proteins probably in the cytoplasm
(Brostrom and Brostrom, 1998). In comparison, Grp78 is a
protein chaperone in the ER. Our data show that
hyperthermia induced Grp78, and suggest that heat also
denatures proteins and causes accumulation of misfolded
proteins in the ER. Thus, it makes sense that hyperthermia can
induce ER stress and ER-mediated apoptosis.
Since Grp78 is a protein chaperone, it can help to resolve
ER stress and protect cells from apoptosis under certain
conditions. Further investigation is necessary to determine
whether agents that inhibit Grp78 will synergize with
hyperthermia treatment.
Induction of apoptosis involves the activation of cascade
caspases through three major apoptotic pathways (Figure 8):
extrinsic, intrinsic, and ER-mediated pathways. Many con-
ventional anticancer agents act through intrinsic and/or
extrinsic apoptotic signaling mechanisms, which are im-
paired in many tumor cells, leading to therapy resistance
(Linder and Shoshan, 2005).
Both melanoma and BCC have been shown to be
resistant to extrinsic and/or intrinsic apoptotic pathways,
either due to the activation of Ras/Raf/Mek/Erk pathways and
phosphatidylinositol 3-kinase/Akt pathways in melanomas
(Hersey, 2006) or inappropriate activation of the Sonic
Hedgehog signaling pathway and its downstream targets in
BCC (Athar et al., 2004; Tang et al., 2006).
It is biologically plausible that when melanoma and BCC
cells are treated with hyperthermia, their ability to inhibit
intrinsic and extrinsic apoptotic pathways force these cells to
die through ER-mediated apoptosis.
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expression in A375 cells. (b) Grp78 and full-length Caspase 12 expression in ASZ001 cells.
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Recently, the ER has been proposed as a promising
anticancer target and mediator of apoptosis, which may be
less affected by intrinsic or chemotherapy-induced resistance
mechanisms (Linder and Shoshan, 2005). Some emerging
evidence indicates the anticancer potential of ER stress-
inducing agents. Thapsigargin sensitizes tumor cells to TRAIL-
induced cell death (Huang et al., 2004), and tunicamycin
increased the sensitivity of head-and-neck tumor cell lines to
cisplatin in vitro and in vivo (Noda et al., 1999). The idea that
hyperthermia induces ER-mediated apoptosis might help
explain why hyperthermia is a very promising treatment
when combined with radiation or chemotherapies (Wust
et al., 2002; Jones et al., 2005). Hyperthermia plus other
apoptosis inducers such as radiotherapy or chemotherapy
may synergize by simultaneously activating multiple apopto-
tic pathways.
In summary, our data suggest that hyperthermia treatment
induces apoptosis in a non-conventional way that is not
through the extrinsic or intrinsic pathways, but rather through
ER-mediated apoptosis in melanoma and non-melanoma skin
cancer cells. These results point to a new perspective of
hyperthermia cytotoxicity, and might provide the scientific
basis for developing cancer therapy with hyperthermia
treatment as a single agent or as a part of rational
combinations especially in cancer cells resistant to intrinsic
or extrinsic apoptotic pathways.
MATERIALS AND METHODS
Cell lines and culture conditions
A human melanoma cell line, A375, a squamous carcinoma cell line
HaCaT, and an epidermoid carcinoma A431 were obtained from
ATCC (Manassas, VA). A primary human melanoma cell line,
WM35, and a metastatic melanoma cell line, HS294T, were kindly
provided by Dr Meenhard Herlyn (Wistar Institute, Philadelphia,
PA). A mouse BCC cell line (ASZ001) (Xie et al., 2001) was kindly
provided by Dr Ervin Epstein Jr. at UCSF. The mouse BCC cell line
ASZ001 was maintained in 254CF medium (Cascade Biologics,
Portland, OR) with 0.05mM CaCl2 and 10% Chelexed fetal bovine
serum (Chelex 100 Resin; Bio-Rad, Hercules, CA). Other cells were
maintained in RPMI 1640 (Invitrogen, Grand Island, NY) with 10%
fetal bovine serum (Gemini Bio-Products Inc., West Sacramento,
CA). All cells were grown as monolayer culture in an incubator set at
37 1C with 5% CO2. The medical ethical committee of UCDHSC at
Anschutz Medical Campus approved all described studies.
Hyperthermia treatments
Cells were treated using methods we described previously (Shellman
et al., 2004). Briefly, cells were grown in 96-well plates with 100ml
medium using standard culture conditions overnight before treat-
ment. Plates were then transferred onto pre-heated copper blocks in
treatment incubators set at the indicated temperatures for the
indicated amounts of time before being transferred back to the
37 1C incubator. We have shown that contact between copper
blocks and the lower surface of 96-well plates in an incubator
provides a highly reproducible heating method (Shellman et al.,
2004). To treat cells for use in western blot, cells were grown
overnight in 10 cm dishes and then heat-treated using the same
methods at 45 1C for 60 or 90minutes before being subjected to
sample preparation for western blot at indicated post-treatment time
points.
Cell Titer 96 Aqueous One solution cell proliferation assay for
quantification of cell viability (MTS assay)
The reagents were obtained from Promega (Madison, WI), and
procedures were followed according to the manufacturer’s instruc-
tions (Cory et al., 1991; Kaliberov et al., 2004). Briefly, assays were
performed by adding 20 ml of the reagent to each well containing
cells with 100 ml medium for 1–4 hours, and OD readings at 490 nm
were recorded with a microplate reader BioKinetics Reader EL312e
(Bio-tek Instruments Inc., Winooski, VT). The optical density
readings for growth media alone were used as background readings.
Caspase Glo 3/7, Caspase Glo 8, or Caspase Glo 9 activity
assays
The reagents were obtained from Promega, and procedures were
followed according to the manufacturer’s instructions. The Caspase-
Glo assays are homogeneous luminescent assays that measure
specific caspase activities by providing proluminescent caspase-
specific substrates linked to aminoluciferin and a proprietary
thermostable luciferase in a reagent optimized for caspase activity,
luciferase activity, and cell lysis. Caspase 3, 8, or 9 assays contain
DEVD, LETD, or LEHD aminoluciferin substrates, respectively. The
relative luminescent unit readings of luminescence are proportional
to caspase activity and were recorded with a microplate reader
BioKinetics Reader EL312e (Bio-tek Instruments Inc.). The readings
for growth media alone were used as background readings.
EB/AO morphologic assay for quantifying apoptosis and
necrosis
To determine the percentage of live, apoptotic, or necrotic cells, the
assays were performed as we described previously (Ribble et al.,
2005). AO and EB were purchased from Sigma (St Louis, MO). The
dye mix for the EB/AO staining was 100mgml1 AO and 100 mgml1
EB in phosphate-buffered saline (PBS). This assay is based on the fact
that apoptosis induces characteristic nuclear condensation and
fragmentation, whereas necrosis is characterized by the inability to
exclude vital dye, leading to orange staining of nuclei.
Briefly, plates were centrifuged, dye mixtures were added to
individual wells, cells were viewed under an inverted fluorescent
microscope, and images were obtained at the indicated post-
treatment times.
Immunoblot. Cells, floating and adherent, were harvested with 1
Laemmli sample buffer (Bio-Rad) at indicated post-treatment time
points. Lysates were heated at 95 1C for 5–10minutes and then
clarified by centrifugation at 13,200 g for 5minutes. Samples were
run on SDS-PAGE 4–20% acrylamide gradient gels (Bio-Rad) and
transferred to polyvinylidene difluoride membranes using a Trans-
blot SD Semi-Dry Transfer Cell apparatus (Bio-Rad) at 15V for
30minutes. Membranes were probed with primary antibodies in PBS
with 5% non-fat milk (or Tris-buffered saline/0.1% Tween with 5%
non-fat milk if specified by the manufacturer), then washed with PBS
for 5minutes, Tris-buffered saline/Tween for 2 5minutes, then PBS
for 5minutes, and incubated with horseradish peroxidase (HRP)-
conjugated secondary antibodies in PBS with 5% non-fat milk. Blots
were developed with HRP substrate (West Pico or Femto developing
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solutions; Pierce, Rockford, IL) for 5minutes at room temperature
and analyzed using a Chemi-doc chemiluminescence detector (Bio-
Rad). The following antibodies were used at the suggested dilution
from manufacturer: Caspase 3, Caspase 12, and a/b-tubulin from
Cell Signaling Technology (Danvers, MA); mouse anti-Caspase 4
mAb from Stressgen Bioreagents (Ann Arbor, MI); anti-actin mouse
mAb and HRP-conjugated goat anti-mouse IgM from EMD
Biosciences Inc. (San Diego, CA); BiP/Grp78 and HRP-conjugated
goat anti-rabbit IgG from BD Transduction Laboratories (San Jose,
CA); and HRP-conjugated goat anti-mouse IgG from Jackson
Immuno-Research (West Grove, PA).
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